EDIT - Editas Medicine, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
25,037
31,937
13,728
6,053
1,629
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
1,629
Operating Expenses
Research Development
76,045
90,654
83,159
56,979
18,846
Selling General and Administrative
58,415
55,010
50,502
46,262
18,095
Total Operating Expenses
134,460
145,664
133,661
103,241
36,941
Operating Income or Loss
-109,423
-113,727
-119,933
-97,188
-35,312
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-119
328
587
-57
-37,445
Income Before Tax
-103,328
-109,954
-120,324
-97,183
-72,900
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-103,328
-109,954
-120,324
-97,183
-72,900
Net Income
-103,328
-109,954
-120,324
-97,230
-73,294
Net Income available to common shareholders
-103,328
-109,954
-120,324
-97,230
-73,294
Reported EPS
Basic
-
-2.33
-2.98
-3.02
-2.05
Diluted
-
-2.33
-2.98
-3.02
-2.05
Weighted average shares outstanding
Basic
-
47,098
40,324
32,220
35,700
Diluted
-
47,098
40,324
32,220
35,700
EBITDA
-
-113,727
-119,933
-97,188
-35,312